Invitrogen Is First Licensee Under ABI's
Expanded PCR Licensing Program

Applied Biosystems has granted the first license under its new expanded PCR-licensing program to Invitrogen, ABI said this week.

The expanded program includes patents for real-time PCR and other PCR-related technology not licensed under Applied Biosystems' previous PCR-licensing program, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.